National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 49889 [2024-12831]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 114 / Wednesday, June 12, 2024 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Integrated Preclinical/
Clinical AIDS Vaccine Development Program
(IPCAVD) (U19 Clinical Trial Not Allowed).
Date: July 11–12, 2024.
Time: 10:00 a.m. to 6:00 p.m..
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane Rockville, MD
20892 (Video Assisted Meeting).
Contact Person: Stephen A. Gallo, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, MSC 9834, Rockville, MD
20892, (240) 669–2858, steve.gallo@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 6, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–12831 Filed 6–11–24; 8:45 am]
ddrumheller on DSK120RN23PROD with NOTICES1
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
17:43 Jun 11, 2024
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Mental Health Services Research Not
Involving Clinical Trials.
Date: July 15, 2024.
Time: 12:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Aileen Schulte, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Bethesda, MD 20892–9608, 301–443–1225,
aschulte@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: June 6, 2024.
David W Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–12836 Filed 6–11–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of Refugee Resettlement
Statement of Organization, Functions,
and Delegations of Authority
Office of Refugee Resettlement,
Administration for Children and
Families, HHS.
ACTION: Notice; realignment of the Office
of Refugee Resettlement.
AGENCY:
The Administration for
Children and Families (ACF) has
realigned the Office of Refugee
Resettlement (ORR). This notice makes
ORR’s Refugee Program and
Unaccompanied Children Program the
Refugee Program Bureau and the
Unaccompanied Children Bureau,
respectively; creates the Bureau of
Operations; and aligns divisions with
the bureau they support.
FOR FURTHER INFORMATION CONTACT:
Michael Smith, Chief Operating Officer,
Office of Refugee Resettlement, 330 C
SUMMARY:
BILLING CODE 4140–01–P
VerDate Sep<11>2014
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Jkt 262001
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
49889
Street SW, Washington, DC 20201,
phone 202–401–4657.
SUPPLEMENTARY INFORMATION: This
notice amends Part K of the Statement
of Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (HHS), Administration for
Children and Families (ACF), as
follows: Chapter KR, Office of Refugee
Resettlement, as last amended by 85 FR
85643, 2020–28706 (December 29,
2020).
I. Under Chapter KR, Office of
Refugee Resettlement, delete KR.10
Organization in its entirety and replace
with the following:
KR.10 Organization. The Office of
Refugee Resettlement (ORR) is headed
by a Deputy Assistant Secretary for
Humanitarian Services and Director,
who reports directly to the Assistant
Secretary for Children and Families.
The office is organized as follows:
Office of the Director/Deputy Assistant
Secretary for Humanitarian Services
(KRA)
Refugee Program Bureau (KRB)
Division of Refugee Assistance (KRB1)
Division of Refugee Services (KRB2)
Division of Refugee Health (KRB3)
Division of Refugee Children Services
(KRB4)
Division of Refugee Policy (KRB5)
Division of Monitoring, Evaluation, and
Learning (KRB6)
Division of Refugee Data and
Information (KRB7)
Division of Interagency Outreach and
Response (KRB8)
Unaccompanied Children Bureau (KRC)
Division of Unaccompanied Children
Services (KRC1)
Division of Planning and Logistics
(KRC2)
Division of Health for Unaccompanied
Children (KRC3)
Division of Unaccompanied Children
Field Operations (KRC4)
Division of Unaccompanied Children
Policy (KRC5)
Division of Unaccompanied Child
Protection Investigations (KRC6)
Division of Grants Management (KRC7)
Division of Unaccompanied Children
Placements (KRC8)
Division of Quality Improvement and
Performance Management (KRC9)
Division of Unaccompanied Children
Data Analytics and Information
Management (KRC10)
Bureau of Operations (KRD)
Division of Budget Planning and
Analysis (KRD1)
Division of Office Operations (KRD2)
Division of Acquisitions Requirements
(KRD3)
Division of Technology (KRD4)
E:\FR\FM\12JNN1.SGM
12JNN1
]]>Agencies
[Federal Register Volume 89, Number 114 (Wednesday, June 12, 2024)]
[Notices]
[Page 49889]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12831]
[[Page 49889]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Integrated Preclinical/Clinical
AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not
Allowed).
Date: July 11-12, 2024.
Time: 10:00 a.m. to 6:00 p.m..
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane Rockville, MD 20892
(Video Assisted Meeting).
Contact Person: Stephen A. Gallo, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, MSC 9834,
Rockville, MD 20892, (240) 669-2858, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: June 6, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-12831 Filed 6-11-24; 8:45 am]
BILLING CODE 4140-01-P
